Alveolar pentraxin 3 as an early marker of microbiologically confirmed pneumonia: a threshold-finding prospective observational study

[1]  A. Mantovani,et al.  Genetic PTX3 deficiency and aspergillosis in stem-cell transplantation. , 2014, The New England journal of medicine.

[2]  R. Fumagalli,et al.  Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial , 2014, Critical Care.

[3]  Chan Kwon Park,et al.  Pleural Fluid Pentraxin-3 for the Differential Diagnosis of Pleural Effusions , 2013, Tuberculosis and respiratory diseases.

[4]  Biao Zhu,et al.  Pentraxin 3 in the assessment of ventilator-associated pneumonia: an early marker of severity. , 2013, Heart & lung : the journal of critical care.

[5]  H. Park,et al.  Viral infection in patients with severe pneumonia requiring intensive care unit admission. , 2012, American journal of respiratory and critical care medicine.

[6]  T. Simpson,et al.  Soluble Triggering Receptor Expressed on Myeloid Cells-1 (sTREM-1) as a Diagnostic Marker of Ventilator-Associated Pneumonia , 2012, Respiratory Care.

[7]  Shun-Fa Yang,et al.  Plasma long pentraxin 3 (PTX3) concentration is a novel marker of disease activity in patients with community-acquired pneumonia , 2012, Clinical chemistry and laboratory medicine.

[8]  P. Shah,et al.  Variation in PTX3 is associated with primary graft dysfunction after lung transplantation. , 2012, American journal of respiratory and critical care medicine.

[9]  J. O’Horo,et al.  Is the gram stain useful in the microbiologic diagnosis of VAP? A meta-analysis. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Frédérique Jacobs,et al.  Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?* , 2012, Critical care medicine.

[11]  M. Niederman,et al.  De-escalation therapy: is it valuable for the management of ventilator-associated pneumonia? , 2011, Clinics in chest medicine.

[12]  L. Guerra,et al.  Lung regional metabolic activity and gas volume changes induced by tidal ventilation in patients with acute lung injury. , 2011, American journal of respiratory and critical care medicine.

[13]  C. Garlanda,et al.  The Therapeutic Potential of the Humoral Pattern Recognition Molecule PTX3 in Chronic Lung Infection Caused by Pseudomonas aeruginosa , 2011, The Journal of Immunology.

[14]  J. Marshall,et al.  Multinational, observational study of procalcitonin in ICU patients with pneumonia requiring mechanical ventilation: a multicenter observational study , 2011, Critical care.

[15]  S. Campo,et al.  Efficacy of PTX3 in a Rat Model of Invasive Aspergillosis , 2010, Antimicrobial Agents and Chemotherapy.

[16]  F. Tubach,et al.  Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial , 2010, The Lancet.

[17]  A. Mantovani,et al.  Persisting high levels of plasma pentraxin 3 over the first days after severe sepsis and septic shock onset are associated with mortality , 2010, Intensive Care Medicine.

[18]  G. T. ten Velde,et al.  Soluble Triggering Receptor Expressed on Myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia , 2009, Intensive Care Medicine.

[19]  A. Mantovani,et al.  PENTRAXIN 3 AND C-REACTIVE PROTEIN IN SEVERE MENINGOCOCCAL DISEASE , 2009, Shock.

[20]  古谷 良輔,et al.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. , 2008, American journal of respiratory and critical care medicine.

[21]  A. Mantovani,et al.  Pentraxin 3 in acute respiratory distress syndrome: An early marker of severity* , 2008, Critical care medicine.

[22]  Margaret A Dudeck,et al.  CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. , 2008, American journal of infection control.

[23]  M. Eisenhut.  Acute lower respiratory tract infection. , 2008, The New England journal of medicine.

[24]  A. Mantovani,et al.  Antiviral Activity of the Long Chain Pentraxin PTX3 against Influenza Viruses1 , 2008, The Journal of Immunology.

[25]  C. Garlanda,et al.  The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps , 2007, The Journal of experimental medicine.

[26]  Anthony S McLean,et al.  Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. , 2007, The Lancet. Infectious diseases.

[27]  A. Mantovani,et al.  Elevated plasma levels of the long pentraxin, pentraxin 3, in severe dengue virus infections , 2005, Journal of medical virology.

[28]  M. Béné,et al.  Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. , 2004, The New England journal of medicine.

[29]  V. Torri,et al.  Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients , 2001, Critical care medicine.

[30]  J P Kahan,et al.  The reproducibility of a method to identify the overuse and underuse of medical procedures. , 1998, The New England journal of medicine.

[31]  J. Vincent,et al.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure , 1996, Intensive Care Medicine.

[32]  S. Lemeshow,et al.  A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study , 1993 .

[33]  R. Auckenthaler,et al.  Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid. , 1991, The American review of respiratory disease.

[34]  C. Garlanda,et al.  Pentraxins in humoral innate immunity. , 2012, Advances in experimental medicine and biology.

[35]  D. Mozingo.  A randomized trial of diagnostic techniques for ventilator-associated pneumonia. , 2006, The New England journal of medicine.

[36]  W. Youden,et al.  Index for rating diagnostic tests , 1950, Cancer.

[37]  F. Bouchonnet,et al.  bronchoalveolar lavage fluid , 2022 .